This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Brazilian Congress of Endocrinology | |
|---|---|
| Name | Brazilian Congress of Endocrinology |
| Native name | Congresso Brasileiro de Endocrinologia |
| Status | Active |
| Genre | Scientific conference |
| Frequency | Annual |
| Location | Brasília, São Paulo, Rio de Janeiro |
| Country | Brazil |
| First | 1970s |
| Organizer | Brazilian Society of Endocrinology and Metabolism |
Brazilian Congress of Endocrinology is the principal annual meeting of the Brazilian Society of Endocrinology and Metabolism convening clinicians, researchers, and policymakers in Brasília, São Paulo, and Rio de Janeiro. The congress serves as a forum for presentation of clinical trials, basic science, and public-health initiatives linking institutions such as the University of São Paulo, Federal University of Rio de Janeiro, Oswaldo Cruz Foundation, Institute of Biomedical Sciences (University of São Paulo), and international partners including the World Health Organization, International Diabetes Federation, and Endocrine Society. Delegates frequently include representatives from the National Institutes of Health, Wellcome Trust, European Society of Endocrinology, American Diabetes Association, and funding agencies such as the São Paulo Research Foundation.
The congress traces its origins to periodic meetings of the Brazilian Society of Endocrinology and Metabolism in the 1970s and formalized as an annual congress during the 1980s, influenced by exchanges with the Endocrine Society (United States), European Society of Endocrinology, and Latin American bodies like the Latin American Diabetes Association. Early iterations featured seminal presentations by faculty from the University of São Paulo, Federal University of Minas Gerais, Pontifical Catholic University of Rio de Janeiro, and visiting scholars from the National Institutes of Health, Imperial College London, Karolinska Institute, and Pasteur Institute. Milestones include the integration of endocrine surgery symposia with the Brazilian College of Surgeons, rollout of national guidelines alongside the Ministry of Health (Brazil), and collaborations with the Brazilian Diabetes Society and the Pan American Health Organization.
The congress is organized by the Brazilian Society of Endocrinology and Metabolism executive board, elected under statutes modeled on professional bodies such as the American Medical Association, Royal College of Physicians, and the International Hospital Federation. Oversight committees include scientific, continuing medical education, and ethics panels with members from the Federal Council of Medicine (Brazil), National Council for Scientific and Technological Development, and university departments like University of Campinas and Federal University of Rio Grande do Sul. Partnerships have been established with publishers such as Elsevier, Springer Nature, and Wiley-Blackwell for proceedings, and with registries including the Brazilian Clinical Trials Registry for trial disclosures.
Programs combine plenary lectures, symposiums, poster sessions, and workshops modeled after conferences like the American Diabetes Association Scientific Sessions, European Association for the Study of Diabetes meetings, and the International Congress of Endocrinology. Recurring themes include diabetes mellitus research linked to the International Diabetes Federation priorities, obesity studies referencing the World Obesity Federation, thyroid disease with input from the American Thyroid Association, adrenal disorders paralleling sessions at the Endocrine Society Annual Meeting, and pediatric endocrinology with contributions from the European Society for Paediatric Endocrinology. Translational tracks often feature collaborations with Fiocruz, the Butantan Institute, and biotechnology firms tied to the Brazilian Association of Biotech. Methodological courses draw on guidelines from the CONSORT and STROBE statements and speakers from institutions such as Harvard Medical School, Johns Hopkins University, Massachusetts Institute of Technology, University of Cambridge, and University of Oxford.
Attendees include endocrinologists, diabetologists, pediatricians, surgeons, basic scientists, residents, and allied-health professionals from Brazilian states like São Paulo (state), Rio de Janeiro (state), and Minas Gerais (state), and from countries including the United States, United Kingdom, Argentina, Chile, Germany, France, Japan, and South Africa. Industry participation features pharmaceutical companies analogous to Novo Nordisk, Eli Lilly and Company, Sanofi, Pfizer, and medical-device exhibitors influenced by standards from the Brazilian Health Regulatory Agency. Continuing medical education credits align with the Brazilian Medical Association accreditation and international frameworks from the European Accreditation Council for Continuing Medical Education.
The congress bestows honors modeled after awards such as the Nobel Prize in Physiology or Medicine-style legacy of recognition within medicine, with named prizes and scholarships funded by foundations like the São Paulo Research Foundation and corporate sponsors reminiscent of grants from Wellcome Trust and the Bill & Melinda Gates Foundation. Categories recognize best oral presentation, best poster, lifetime achievement in endocrinology (echoing honors from the Endocrine Society), and young-investigator awards similar to those by the European Society of Endocrinology and the American Diabetes Association.
The congress has influenced national clinical practice guidelines disseminated through the Ministry of Health (Brazil) and professional societies comparable to the Brazilian Medical Association and Brazilian Society of Cardiology, shaping policy on noncommunicable diseases in coordination with the Pan American Health Organization. Research presented has led to multicenter collaborations with the National Institutes of Health, technology transfer initiatives with the Butantan Institute, and publications in journals affiliated with Elsevier, Springer Nature, and the American Association for the Advancement of Science. The meeting has fostered capacity building at universities such as University of São Paulo, Federal University of Rio de Janeiro, and Federal University of Ceará and strengthened ties to international networks including the International Diabetes Federation, Endocrine Society, and World Health Organization.
Category:Medical conferences in Brazil